Clinical trial

A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the…

NCT00382772 · GlaxoSmithKline, Industry · Completed

Key facts

NCT number NCT00382772
Title A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).
Official title Study to Evaluate Clinical Consistency of the Liquid Formulation of GSK Biologicals' HRV Vaccine and to Evaluate Liquid Formulation Compared to Lyophilised Formulation of the HRV Vaccine Administered as a Two-dose Primary Vaccination.
Lead sponsor GlaxoSmithKline, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Infections, Rotavirus
Intervention type Biological
Interventions 2-dose oral live attenuated G1P[8] human rotavirus vaccine
Enrollment 1,200
Start date Nov 1, 2006
Primary completion Apr 1, 2007
Completion Aug 1, 2007
First posted Oct 2, 2006
Last update posted Nov 4, 2016
Countries Finland

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies